SynthesisBMC surgery2025
Robotic versus laparoscopic right colectomy with complete mesocolon excision for right-sided colon cancer: a systematic review and meta-analysis.
Synthesis in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Feasibility of robotic-assisted right colectomy using the "squeezing approach".Surgery today · 2026Article
- Comparison of surgical outcomes between robot-assisted and laparoscopic right colectomy for colon cancer: a single-center cohort study.Journal of robotic surgery · 2026Article
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRight colectomy with complete mesocolic excision (CME) is considered the standard for right-sided colon cancer. While laparoscopic CME (LCME) is widely performed, robotic CME (RCME) has emerged as an alternative approach. This systematic review and meta-analysis compared the perioperative, pathological, and oncological outcomes of RCME and LCME.
methodsFollowing PRISMA 2020 guidelines, randomized and controlled clinical trials comparing RCME and LCME were analyzed. Primary outcomes included operative morbidity, blood loss, bleeding, conversion to open surgery, and operative time. Odds ratios (OR) or mean differences (MD) with 95% confidence intervals (CIs) were calculated using a random-effects model. Certainty of evidence was assessed using GRADE.
resultsSeven studies comprising 733 patients (364 RCME and 369 LCME) were included. Postoperative morbidity did not differ significantly between RCME and LCME (OR 0.95, 95% CI 0.66-1.37; p = 0.79). Blood loss was comparable between groups (MD - 4.6 mL, 95% CI - 27.7 to 18.5; p = 0.70). RCME showed a lower conversion rate to open surgery (OR 0.07, 95% CI 0.01-0.52; p = 0.01), though this was based on a few events and low-certainty evidence. Operative time was longer with RCME (MD 45.6 min, 95% CI 27.5-63.8; p < 0.00001). There were no significant differences in postoperative ileus (OR 0.88, 95% CI 0.40-1.92; p = 0.74), hospital stay (MD - 0.10 days, 95% CI - 0.61 to 0.40; p = 0.69), or lymph node yield (MD 2.05, 95% CI - 1.53-5.63; p = 0.26). Oncological outcomes were similar between RCME and LCME for disease-free survival (OR 1.25, 95% CI 0.48-3.30; p = 0.65) and overall survival (OR 1.00, 95% CI 0.14-7.20; p = 1.00). The certainty of evidence ranged from low to moderate for most endpoints.
conclusionsRCME and LCME demonstrate comparable surgical, pathological, and oncological outcomes. RCME may be associated with a lower conversion rate, though this finding is uncertain due to the limited number of events and inter-study heterogeneity. Further high-quality randomized trials are warranted to confirm these observations and clarify cost-effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.